National Health Investors, Inc. (NHI) Rating Reiterated by Stifel Nicolaus
National Health Investors, Inc. (NYSE:NHI)‘s stock had its “buy” rating reissued by research analysts at Stifel Nicolaus in a report issued on Wednesday. They presently have a $82.00 target price on the real estate investment trust’s stock. Stifel Nicolaus’ price target indicates a potential upside of 5.68% from the company’s previous close.
Other equities research analysts have also recently issued research reports about the stock. Zacks Investment Research raised shares of National Health Investors from a “hold” rating to a “buy” rating and set a $90.00 target price for the company in a research report on Tuesday, September 5th. Mizuho reaffirmed a “neutral” rating on shares of National Health Investors in a report on Wednesday, June 28th. BidaskClub cut shares of National Health Investors from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Finally, ValuEngine cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. National Health Investors presently has an average rating of “Hold” and a consensus target price of $80.20.
Shares of National Health Investors (NHI) traded up 0.10% during trading on Wednesday, reaching $77.67. 27,341 shares of the company were exchanged. The company’s 50-day moving average is $79.15 and its 200 day moving average is $76.56. The firm has a market capitalization of $3.18 billion, a PE ratio of 19.95 and a beta of 0.56. National Health Investors has a 1-year low of $66.31 and a 1-year high of $81.21.
National Health Investors (NYSE:NHI) last posted its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing the Zacks’ consensus estimate of $1.29 by ($0.36). National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The firm had revenue of $69.84 million for the quarter, compared to analysts’ expectations of $67.68 million. During the same period in the previous year, the company earned $1.22 EPS. The company’s revenue was up 14.1% on a year-over-year basis. Equities research analysts expect that National Health Investors will post $3.85 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “National Health Investors, Inc. (NHI) Rating Reiterated by Stifel Nicolaus” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/10/06/national-health-investors-inc-nhi-rating-reiterated-by-stifel-nicolaus.html.
In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of the firm’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the completion of the transaction, the insider now owns 21,228 shares of the company’s stock, valued at $1,693,994.40. The transaction was disclosed in a filing with the SEC, which is available at this link. Company insiders own 5.19% of the company’s stock.
Several large investors have recently added to or reduced their stakes in NHI. UBS Asset Management Americas Inc. increased its stake in shares of National Health Investors by 19.5% in the first quarter. UBS Asset Management Americas Inc. now owns 72,214 shares of the real estate investment trust’s stock worth $5,245,000 after acquiring an additional 11,776 shares during the period. Karp Capital Management Corp acquired a new stake in shares of National Health Investors in the first quarter worth $849,000. Parametric Portfolio Associates LLC increased its stake in shares of National Health Investors by 2.2% in the first quarter. Parametric Portfolio Associates LLC now owns 47,473 shares of the real estate investment trust’s stock worth $3,448,000 after acquiring an additional 1,016 shares during the period. Oxford Asset Management acquired a new stake in shares of National Health Investors in the first quarter worth $972,000. Finally, Quantbot Technologies LP acquired a new stake in shares of National Health Investors in the first quarter worth $201,000. Hedge funds and other institutional investors own 70.67% of the company’s stock.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.